Clinical Trial Update: RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension [Phase 1]

View source ↗

Summary

This is a Phase 1 feasibility trial evaluating catheter-based renal denervation to treat resistant hypertension, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Renovascular Hypertension

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Hypertension, Renal | Phase 1 | Status: COMPLETED | Results posted: 2015-08-25